Wide Ranks

ASND

Ascendis Pharma A/S

136.31

Top Statistics
Market Cap 8 B Forward PE -40.37 Revenue Growth -24.00 %
Current Ratio 0.74 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -154.12 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -22.09 Enterprise / Revenue 24.14 Price To Sales Trailing12 Months 25.65
Profitability
Profit Margins -154.12 % Operating Margins -370.18 %
Balance Sheet
Total Cash 258 M Total Cash Per Share 4.51 Total Debt 672 M
Total Debt To Equity Current Ratio 0.74 Book Value Per Share -2.57
All Measures
Short Ratio 850.00 % Message Board Id finmb_39510693 Shares Short Prior Month 3 M
City Hellerup Uuid 68400868-eb49-3e91-a1a2-ed438c4632e5 Previous Close 134.60
First Trade Date Epoch Utc 1 B Book Value -2.57 Beta 0.6540
Total Debt 672 M Volume 206508 Fifty Two Week Low 97.86
Total Cash Per Share 4.51 Total Revenue 317 M Shares Short Previous Month Date 1 B
Target Median Price 177.96 Max Age 86400 Recommendation Mean 1.29
Sand P52 Week Change 0.3133 Operating Margins -370.18 % Target Mean Price 181.98
Net Income To Common -489516000 Short Percent Of Float 0.0803 Implied Shares Outstanding 59 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 640300
Average Volume10days 640300 Total Cash 258 M Next Fiscal Year End 1 B
Revenue Per Share 5.59 Held Percent Insiders 0.0073 Ebitda Margins -109.31 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 134.60 Target Low Price 145.03 Gmt Off Set Milliseconds -18000000
Fifty Day Average 132.55 Open 134.54 Free Cashflow -104128496
Dividend Yield 0.00 % Return On Assets -0.2792 Time Zone Short Name EST
Trailing Eps -7.82 Day Low 132.38 Address1 Tuborg Boulevard 12
Shares Outstanding 59 M Price Hint 2 Target High Price 273.94
Website https://ascendispharma.com 52 Week Change 0.3573 Average Volume 656107
Forward Eps -3.95 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 40.00 % Is_sp_500 False Regular Market Day High 136.45
Profit Margins -154.12 % Fifty Two Week High 161.00 Day High 136.45
Shares Short 3 M Regular Market Open 134.54 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 24.14 Revenue Growth -24.00 %
Shares Percent Shares Out 0.0570 Operating Cashflow -330079008 Currency USD
Time Zone Full Name America/New_York Market Cap 8 B Is_nasdaq_100 False
Zip 2900 Quote Type EQUITY Industry Biotechnology
Long Name Ascendis Pharma A/S Regular Market Day Low 132.38 Held Percent Institutions 1.07
Current Price 136.31 Enterprise To Ebitda -22.09 Financial Currency EUR
Current Ratio 0.74 Gross Margins 85.56 % Industry Disp Biotechnology
Number Of Analyst Opinions 14 Country Denmark Float Shares 56 M
Two Hundred Day Average 136.57 Enterprise Value 7 B Price To Sales Trailing12 Months 25.65
Forward PE -40.37 Regular Market Volume 206508 Ebitda -347192992
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs.

It offers SKYTROFA for treating patients with growth hormone deficiency (GHD).

The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.